Sahil Kirpekar, Chief Business Officer at ATAI Life Sciences N.V. (ATAI), sold 71,602 shares at $1.85 ($132K) on 2024-04-02, disclosed to the SEC on 2024-04-04.
Open-market sale of $132k ATAI by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.85 | 35,801 | $66K | 50.0% |
| 2 | $1.85 | 35,801 | $66K | 50.0% |
| Total | $1.85 avg | 71,602 | $132K | 100% |